Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68d5120969ae9dc39d88b07663480d6a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56905 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
filingDate |
2020-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d25afcb3b06703008e3f042345f44bfa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_727ee99a77500a5ffb649e9362590e5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8bbea8028d41b61c988aa04ee1da114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9838b86f66ed378f0287274812075db2 |
publicationDate |
2021-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2021057003-A1 |
titleOfInvention |
Schistosoma haematobium recombinant fusion protein shsap and application thereof in immunodiagnosis of schistosomiasis |
abstract |
A Schistosoma haematobium recombinant fusion protein ShSAP and an application thereof in the immunodiagnosis of schistosomiasis. The Schistosoma haematobium recombinant fusion protein ShSAP can undergo large-scale standardized mass production by means of genetic engineering technology, antigen quality is stable and the repeatability of the results is good. The fusion protein can be used for the immunodiagnosis of both schistosomiasis haematosis and schistosomiasis mansoni, and has extremely high sensitivity. The Schistosoma haematobium recombinant fusion protein ShSAP has a single antigen component, and ShSAP-ELISA has excellent specificity for the immunodiagnosis of schistosomiasis. The fusion protein does not cross-react with the serum of a patient suffering from another parasitic disease, and has broad application prospects. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112779277-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112779277-A |
priorityDate |
2019-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |